ask="3.60"
ask_size="500"
average_daily_volume="223550"
bid="2.05"
bid_size="100"
book_value="-0.12"
change="+0.00"
change_from_200_day_moving_average="0.12"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-0.88"
change_From_52_week_low="0.80"
change_in_percent="+0.00%"
close="3.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.95"
ebitda="-29.91M"
eps_estimate_current_year="-1.04"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.71"
ex_dividend_date="N/A"
float_shares="26692000"
high="3.26"
high_52_weeks="4.08"
last_trade_date="3/13/2017"
last_trade_price="3.20"
last_trade_size="3782"
last_trade_time="4:00pm"
low="3.15"
low_52_weeks="2.40"
market_capitalization="145.08M"
moving_average_200_day="3.08"
moving_average_50_day="2.99"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="3.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+3.89%"
percent_change_from_50_day_moving_average="+6.92%"
percent_change_from_52_week_high="-21.55%"
percent_change_from_52_week_low="+33.33%"
previous_close="3.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="8.36"
revenue="17.36M"
shares_outstanding="45336000"
short_ratio="20.25"
stock_exchange="NGM"
symbol="ACRX"
volume="107313"
weeks_range_52="2.40 - 4.08"
